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Is It Time to Extend Synoptic Reporting to Include Non-Malignant Oral Epithelial and 
Lichenoid Lesions? 
Paul C. Edwards
As practicing oral and maxillofacial pathologists, we expect that clinicians who send us tissue 
specimens for interpretation will rely on the biopsy report to guide their treatment.  Synoptic 
reporting, the use of structured checklists to produce standardized biopsy reports that ensures 
inclusion of all clinically important information in a format that is relatively consistent across 
pathology departments and pathologists
1
, is the standard of care for pathology reports of 
excisional biopsies/resections of most malignancies. In our immediate area of expertise, the 
College of American Pathologists (CAP) offers “Cancer Protocol Templates
2
” for resection of
malignancies of the lip and oral cavity, major salivary glands, nasal cavity and paranasal sinuses, 
pharynx, larynx, thyroid, lymphomas, plasma cell neoplasms, tumors of soft tissue 
(including intermediate, locally aggressive neoplasms), as well as biomarker testing of 
specimens from patients with tumors of the head and neck. While the use of synoptic reporting 
templates is only mandated for pathology laboratories accredited through CAP for definitive 
resection specimens, these templates can serve as a valuable resource to ensure that the 
pathologist is providing the referring clinician with important clinical and prognostic 
information such as tumor grade, minimum depth of invasion, lymphovascular invasion, neural 
invasion and inflammatory response, even in the case of incisional biopsies of malignant head 
and neck neoplasms.    
Recognizing the clear benefit of synoptic reporting, why restrict its use to malignant 
neoplasms? Benefits from extending synoptic reporting to non-malignant but potentially 
preneoplastic oral epithelial lesions and lichenoid lesions include improved communication with 
the referring clinician, increased patient understanding and appreciation of the nuances of their 
condition, and improved data collection for studies looking at natural history of disease, 
prognostic factors, and treatment outcomes; all of which should ultimately leaded to more 
effective patient management. 
A significant component of many oral pathology biopsy services involves the evaluation and 
interpretation of the full spectrum of benign oral epithelial lesions that may be associated with 
a greater than average risk of neoplastic transformation, including lichenoid lesions, 
hyperkeratosis, epithelial hyperplasia, and varying degrees of oral epithelial dysplasia. These 
represent a continuum of conditions that can be challenging, both clinically and 
histopathologically, to assess as well as to manage. Therefore, particularly with respect to the 
spectrum of histopathologically overlapping “potentially preneoplastic oral epithelial lesions” 
(PPOEL) and lichenoid lesions, synoptic reporting would be anticipated to improve 
communication with referring clinicians. While acknowledging the uncertainty that will likely 
always exist with respect to predicting long-term clinical outcome in many of these case, as oral 
and maxillofacial pathologists we are, by most objective measures, the specialists with the most 
expertise in this area. On a daily basis we encounter biopsies from patients with patients with 
oral epithelial lesions with potentially worrisome histopathologic or clinical features that in 
aggregate don't meet objective criteria to be signed out definitively as dysplasia. While we _________________________________________________________________________________
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should not be expected to offer a definitive estimate as to the long-term risk of malignant 
transformation, we all recognize that our assessment of relative risk varies in response to subtle 
histopathologic features and overall clinical presentation. Aggregating these modifiers in a clear 
and concise manner is the main benefit of synoptic reporting for PPOELs. 
Parameters to include on these structured checklists can be divided into discrete categories: i) 
location, type of biopsy (incisional versus excisional) and relevant clinical or social history (e.g. 
20 pack year smoking history; history of squamous cell carcinoma at same site; history of long-
term systemic immunosuppression); ii) an assessment of the degree of confidence in the 
diagnosis (Is the biopsy adequate and representative? Are there accompanying clinical 
photographs and do they support the histopathologic interpretation? Are there confounding 
factors such as ulceration or candidal infections that may result in difficulty assessing if any 
epithelial changes are reactive or neoplastic?); iv) a summary of clinically relevant modifiers 
accompanied by a brief narrative as to the possible significance of these features;  v) a summary 
of any histopathologic modifiers, both positive and negative, of potential clinical significance, 
accompanied by a brief narrative as to the possible significance of these features; vi) itemized 
list of any special stains, staining patterns and brief interpretative overview; vii) overall 
interpretation, including, where applicable, a qualitative assessment of the long-term 
premalignant potential of the lesion, modified by identified risk factors (of course, to include an 
accompanying disclaimer that the overall risk estimate is, at best, an estimation); viii) 
recommendations for further management, as appropriate. 
Collection of the most important diagnostic information needed to fully populate the synoptic 
report can be facilitated by including specific checklist questions on the biopsy submission form 
that accompanies the tissue, as advocated for by Cheng and colleagues in their recent American 
Academy of Oral and Maxillofacial position paper on the diagnosis of oral lichen planus.
3
There is no doubt that many of us currently reference these matters; in the microscopic 
description section, in a separate comment section, or by directly talking to the referring 
clinician. But, from a practical perspective, many clinicians do not have the time or experience 
to interpret the full range of histopathologic nuances that may be contained in the microscopic 
description section of the pathology report. For the busy clinician, managing tens of patients a 
day, the ability to quickly identify the most significant features in the report, in a concise, easy 
to read, and consistent format, only facilitates patient care. A well-constructed synoptic 
reporting section in the biopsy report may even preclude the need for a “microscopic 
description section,” the bulk of which, particularly in an unstructured format, is likely of 
minimal value to the interpreting clinician; in many cases serving instead to increase clutter and 
lead to distraction
4
.   This is of even greater benefit for the non-oral and maxillofacial surgeon
practitioner, who may not routinely see the full spectrum of PPOEL and lichenoid lesions. 
Moreover, the movement towards greater patient involvement in the management of their 
own health will only accelerate. As part of this changing landscape, patient receipt of electronic 
copies of their own biopsy reports will become the norm. Some hospitals are even 
experimenting with a multidisciplinary team approach, in which the pathologist and the 
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surgeon meet directly with the patient to review their pathology report and explain how these 
findings may impact treatment and prognosis
5
.  In this scenario, synoptic reporting of PPOELs 
and lichenoid lesions will help to increase a patient’s appreciation of the nuances of their 
disease
6
 and enhance a patient’s understanding of their clinician’s treatment advice (e.g. the 
recognition that PPOELs represent a chronic condition requiring long-term reassessment and, in 
many cases, repeat biopsies).  
 
Finally, as noted by Cheng and colleagues, with respect to lichenoid lesions, “a structured, 
standardized basis for reporting data is lacking, and important clinical information and/or 
histopathologic evidence are often missing in publications
3
.” The same rationale extends to 
PPOELs, arguing in favor of a third potentially very significant benefit of synoptic reporting: 
improved standardization of data collection. 
 
Acknowledging these factors, it’s clear that for the benefit of our patients with PPOELs and 
lichenoid lesions, and for the referring clinicians who are our partners in their long-term 
management, we must strive to provide relevant information in a concise, consistent and easily 
interpretable format. It clearly is time to extend synoptic reporting to biopsies of non-malignant 
oral epithelial and lichenoid lesions.      
 
 
Respectfully submitted, 
 
Paul C. Edwards 
Oral and Maxillofacial Pathology Section Editor 
Editor, American Academy of Oral and Maxillofacial Pathology 
Professor, Dept. of Oral Pathology, Medicine and Radiology, Indiana University School of 
Dentistry 
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